Established in 1945 in South Korea, Daewoong Pharmaceutical has focused all its efforts on improving people’s health by offering a high value added portfolio, and as a result, it has grown to be one of the market leaders in Korea.

During its whole history, Daewoong Pharmaceutical has been seeking for innovative solutions through its total dedication to healthcare. Boosted by its desire to be the best partner, the company acquired a core competence for new drug development in order to meet diverse medical needs and to enhance people’s quality of life.

Main Products : URSA, NABOTA, OLOSTAR, FEXUCLUE, ENVLO, CREZET, LITORVAZET